Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion description "[Additionally, a recent study revealed a possible beneficial effect of antihuman CD20 antibody (rituximab) therapy for SSc patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion evidence source_evidence_literature NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion SIO_000772 20175836 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion wasDerivedFrom befree-20140225 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_assertion wasGeneratedBy ECO_0000203 NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP881473.RAO1SO5TuCmZWJtR2_L-FWiJw0eGL7XA2VfThsIYbJqhU130_provenance.